Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to explore whether patients with restless legs syndrome (RLS) differ from healthy subjects in daytime and night time autonomic function and cardiovascular risk markers and whether 4 week treatment with pramipexole affects autonomic function and cardiovascular risk markers in patients with RLS.
Epistemonikos ID: 2b1dd452f7c98e4e172f6ed1bce14e8a6327aa17
First added on: May 11, 2024